台股 » 個股 » 台耀 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台耀

(4746)
可現股當沖
  • 股價
    72.5
  • 漲跌
    ▲1.3
  • 漲幅
    +1.83%
  • 成交量
    284
  • 產業
    上市 生技醫療類股
  • 365人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
台耀 (4746)籌碼相關-土銀 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

土銀 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1400.00272.3072.10-2989-0.20%
2025/01/13771.00571.3671.3029900.20%
2025/01/0600.001673.0874.20-16930-1.72%
2024/12/27570.7000.0069.5059090.55%
2024/12/13271.30271.9571.3001,0280.00%
2024/12/1200.00172.3072.20-11,018-0.10%
2024/12/11772.0600.0071.5071,0050.70%
2024/12/10473.6000.0073.6049650.41%
2024/12/02174.9000.0074.7019020.11%
2024/11/2900.00376.6076.00-3895-0.34%
2024/11/27375.4000.0075.0038670.35%
2024/11/20178.70179.4079.1007500.00%
2024/11/190.181.0000.0079.900.17180.01%
2024/10/2400.001193.3091.90-11860-1.28%
2024/10/110.291.0000.0091.800.21,3150.02%
2024/10/081193.1600.0093.30111,3130.84%
2024/10/07196.0000.0095.8011,3170.08%
2024/09/232103.504103.00104.00-21,472-0.14%
2024/09/202101.003100.0099.40-11,468-0.07%
2024/09/1800.00292.9092.90-21,427-0.14%
2024/09/1600.00290.1090.00-21,427-0.14%
2024/09/12187.7000.0087.6011,4320.07%
2024/09/11187.1000.0087.0011,4410.07%
2024/09/09187.5000.0087.5011,4560.07%
2024/09/0600.00588.5088.40-51,459-0.34%
2024/09/05288.1000.0087.0021,4790.14%
2024/08/30397.00596.9096.80-21,583-0.13%
2024/08/2800.00193.5092.70-11,579-0.06%
2024/08/27291.8000.0093.1021,5790.13%
2024/08/16191.9000.0092.1011,6130.06%
2024/08/1400.00292.7091.70-21,622-0.12%
2024/08/1200.00395.6095.70-31,629-0.18%
2024/07/291106.5000.00105.0011,6580.06%
2024/07/191109.5000.00107.0011,5880.06%
2024/07/181115.006112.75110.50-51,556-0.32%
2024/07/171112.502113.50113.50-11,436-0.07%
2024/07/161110.0000.00109.5011,3950.07%
2024/07/151110.005110.00110.00-41,408-0.28%
2024/07/1200.002102.50103.00-21,349-0.15%
2024/07/091101.5000.00101.5011,4410.07%
2024/07/0800.001103.50103.00-11,474-0.07%
2024/07/031103.5000.00103.0011,7100.06%
2024/07/022102.0000.00102.0021,8990.11%
2024/06/25197.70197.1098.0001,9820.00%
2024/06/21199.50298.0097.60-12,145-0.05%
2024/06/20198.1000.0098.2012,1670.05%
2024/06/13197.6000.0097.1012,1770.05%
2024/06/124.298.7000.0097.704.22,1810.19%
2024/06/1100.00699.8099.80-62,191-0.27%
2024/05/2300.00392.0092.40-32,485-0.12%
2024/05/1700.001095.2096.20-102,646-0.38%
2024/05/151193.0500.0093.10112,6770.41%
2024/05/1000.00191.3092.00-12,749-0.04%
2024/05/0900.0018894.4794.60-1882,759-6.81% 大賣/鉅額交易
2024/05/07397.20396.7097.2002,7920.00%
2024/05/03399.30199.5098.7022,9280.07%
2024/04/263101.5000.00100.0033,1120.10%
2024/04/22198.6000.0098.7013,8150.03%
2024/04/191100.5000.00101.0013,8250.03%
2024/04/181106.501105.50106.5003,8180.00%
2024/04/171106.5000.00105.5013,8780.03%
2024/04/1500.000.2110.50110.00-0.23,978-0.01%
2024/04/101.1116.091116.50115.500.14,1060.00%
2024/04/0920.1106.014109.50110.0016.14,0280.40%
2024/04/084.1105.6400.00106.004.13,9730.10%
2024/04/030.2110.506114.58116.50-5.83,832-0.15%
2024/04/013111.503112.50111.5003,7700.00%
2024/03/2900.001108.50107.50-13,744-0.03%
2024/03/281111.0000.00109.0013,7200.03%
2024/03/275110.704105.38112.0013,6950.03%
2024/03/263104.004104.75103.50-13,591-0.03%
2024/03/253102.504102.25102.50-13,593-0.03%
2024/03/2200.0011100.00100.50-113,618-0.30%
2024/03/144100.1300.00101.0043,8020.11%
2024/03/1300.00198.5097.00-13,810-0.03%
2024/03/123100.503101.00100.0003,8130.00%
2024/03/111101.5000.0099.9013,9450.03%
2024/03/081103.003104.50102.00-24,021-0.05%
2024/03/074102.7500.00103.0044,0680.10%
2024/03/0500.003111.00110.00-34,017-0.07%
2024/03/043107.001107.50107.0023,9490.05%
2024/03/0100.004108.38108.00-44,037-0.10%
2024/02/2900.001113.00110.00-14,216-0.02%
2024/02/2600.001112.00113.00-14,273-0.02%
2024/02/231111.004110.38109.50-34,286-0.07%
2024/02/223109.0000.00108.5034,3890.07%
2024/02/215110.806110.92112.00-14,529-0.02%
2024/02/203106.0000.00106.0034,5660.07%
2024/02/191107.0000.00104.0014,5930.02%
2024/02/161109.002109.00106.00-14,660-0.02%
2024/01/311112.0000.00112.5014,6910.02%
台耀子公司台新藥明年中轉上市 拚兩年後損平Anue鉅亨-2023/11/20
台耀 相關文章